PT Otsuka Indonesia
🇮🇩Indonesia
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis
- First Posted Date
- 2009-10-16
- Last Posted Date
- 2013-05-15
- Lead Sponsor
- PT Otsuka Indonesia
- Target Recruit Count
- 55
- Registration Number
- NCT00996788
- Locations
- 🇮🇩
Division of Gastroenterology Department of Internal Medicine - Cipto Mangunkusumo Hospital, Faculty of Medicine University of Indonesia, Jakarta, Indonesia
Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma
Phase 3
Completed
- Conditions
- Moderate Acute Asthma
- Interventions
- Drug: Procaterol, Salbultamol
- First Posted Date
- 2009-10-07
- Last Posted Date
- 2009-10-07
- Lead Sponsor
- PT Otsuka Indonesia
- Target Recruit Count
- 140
- Registration Number
- NCT00990847
- Locations
- 🇮🇩
University of Indonesia/ Persahabatan Hospital, Jakarta, Indonesia
News
No news found